Workflow
3 Under-the-Radar Value AI Stocks With Market-Beating Potential
JCIJohnson Controls(JCI) The Motley Fool·2025-03-20 09:10

Group 1: Johnson Controls - Johnson Controls is projected to generate approximately 4billioninrevenuefromdatacentersin2024,withanestimatedtotalrevenueof4 billion in revenue from data centers in 2024, with an estimated total revenue of 23.4 billion in 2025, indicating that data centers could account for about 19% of its revenue in 2025 [3][4] - The company is experiencing growth in its data center orders, contributing to a growing backlog, while also focusing on retrofit opportunities in commercial buildings to enhance efficiency and meet net zero emissions goals [5] - Johnson Controls is currently trading at an attractive enterprise value to EBITDA ratio, making it a potential buy on dips [5] Group 2: nVent Electric - nVent Electric, which specializes in electrical protection and connections, is positioned to benefit from the electrification trend in various sectors, including smart buildings and data centers [6][7] - The company reported approximately 3billioninsalesfromcontinuingoperationsin2024,withdatasolutionscontributing203 billion in sales from continuing operations in 2024, with data solutions contributing 20% or 600 million, and a 30% growth in data solutions sales, equating to an increase of $139 million [8][9] - nVent anticipates that its infrastructure end markets, particularly data centers, will drive growth with a low double-digit increase expected in 2025 [9] Group 3: GE HealthCare - GE HealthCare is enhancing its value proposition through the growth of AI-enabled solutions, particularly in imaging equipment, where it competes with Siemens Healthineers and Philips [12][13] - The company has expanded its AI-enabled authorizations from 58 to 85 in 2024, aiming to develop precision care solutions that leverage data from its imaging and patient monitoring equipment [14] - The integration of AI is expected to improve diagnostic and treatment capabilities, ultimately leading to better patient outcomes [15]